ConductScience.org, home

Paper1021237

Comparative nephrotoxicity of platinum cancer chemotherapeutic agents.

Ward JM and 5 others. Cancer Treat Rep, 1976. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Comparative nephrotoxicity of platinum cancer chemotherapeutic agents. Papers, record 1021237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1021237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative nephrotoxicity of platinum cancer chemotherapeutic agents.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.36
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ward JMJ M
2Young DMD M
3Fauvie KAK A
4Wolpert MKM K
5Davis RR
6Guarino AMA M

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
KidneyMajor topic
PlatinumMajor topic
Animals
Blood Urea Nitrogen
Cisplatin
Creatinine
Lethal Dose 50
Male
Rats

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
37047059Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury.Int J Mol Sci2023https://conductscience.org/library/papers/37047059PubMed
35159680Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury.Nanomaterials (Basel)2022https://conductscience.org/library/papers/35159680PubMed
15613605Biomonitoring of a worker population exposed to platinum dust in a catalyst production plant.Occup Environ Med2005https://conductscience.org/library/papers/15613605PubMed
8494733Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.Br J Cancer1993https://conductscience.org/library/papers/8494733PubMed
7438327Platinum drugs: combined anti-lymphoproliferative and nephrotoxicity assay in rats.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7438327PubMed
3948299The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948299PubMed
230514Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/230514PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1021237

GET https://conductscience.org/api/papers/v1/1021237/authors